RT Journal Article
T1 Impact of COVID-19 on the cardiovascular surgery departments in Spain: Analysis of the diagnostic-related groups (SECCE-COVID-19 Study phase 2)
A1 Andres Rodriguez-Caulo, Emiliano
A1 Manuel Villaescusa, Jose
A1 Hernandez-Vaquero, Daniel
A1 Aldamiz-Echevarria, Gonzalo
A1 Bustamante-Munguira, Juan
A1 Carnero-Alcazar, Manuel
A1 Berastegui, Elisabeth
A1 Sbraga, Fabrizio
A1 Maria Gonzalez-Santos, Jose
A1 Garrido Jimenez, Jose Manuel
A1 Gutierrez, Encarnacion
A1 Jesus Lopez-Gude, Maria
A1 Laguna, Gregorio
A1 Francisco Valderrama-Marcos, Jose
A1 Juarez, Carlos
A1 Irabien, Angela
A1 Ventosa-Fernandez, Guillermo
A1 Antonio Margarit, Juan
A1 Manuel Gracia-Baena, Juan
A1 Canovas, Sergio
A1 Sadaba, Rafael
A1 Gonzalez-Barbeito, Miguel
A1 Campos, Elena
A1 Miguel Barquero-Aroca, Jose
A1 Grp Estudio SECCE-COVID-19, 
K1 Surgery
K1 COVID-19
K1 SARS-CoV-2
K1 Impact
AB Introduction and objectives: The COVID-19 pandemic caused by the SARS-CoV-2 virus infection has saturated the Spanish health system, affecting the care of cardiovascular diseases. In this phase 2 of the SECCE-COVID-19 study we want to quantify the impact of the pandemic on the number of cardiac surgeries by analyzing the most prevalent diagnostic-related groups (DRGs) in our specialty.Methods: At the request of the Spanish Society of Cardiovascular and Endovascular Surgery (SECCE), all the centers in the national territory that wanted to participate were asked for the data of the DRG codes number 162 (surgery on heart valves with infarction or complex diagnosis), 163 (surgery on heart valves without infarction or complex diagnosis), 165 (coronary bypass with infarction or complex diagnosis), 166 (coronary bypass without infarction or complex diagnosis) and 167 (other cardiothoracic or thoracic vascular procedures) between March 1, 2020 and September 30, 2020 (7 months), and as a control period the same dates of the year 2019.Results: Data were received from 24 Hospital Centers, 22 public and 2 private. There was a global decrease in the number of interventions of 30% (Range -19 a -42%, p
PB Elsevier
SN 1134-0096
YR 2021
FD 2021-07-01
LK http://hdl.handle.net/10668/18734
UL http://hdl.handle.net/10668/18734
LA es
DS RISalud
RD Apr 5, 2025